Skip to main content

News & Events

 May 30, 2013

Dr. Hocking's Work Recognized with TechConnect Innovation Award

Fibronectic Matrix Mimetic technology, developed by Professor Denise Hocking (Pharmacology and PhysiologyBME), was recently recognized with a TechConnect Innovation Award. The TechConnect Innovation Awards recognize the top 20% of technologies at the TechConnect World Summit & Innovation. The technology was presented at TechConnect World by Patrick Emmerling Ph.D, M.B.A. from the UR Office of Technology Transfer. TechConnect World is designed to accelerate the translation of innovations from the laboratory to industry commercialization. Innovation rankings are based on the potential impact of the technology on the industry sector. Fibronectin matrix mimetics are novel extracellular matrix protein-based biologics developed to promote the healing of chronic wounds. The technology falls under a new and exciting class of therapies known as wound biologics.